Abstract
In correspondence with the Diagnosis Procedure Combination (DPC) System of Japan critical paths for malignant lymphoma (ABVD regimen, Biweekly CHOP regimen, R-CHOP regimen, R-FND regimen) and acute myeloid leukemia (AML) (remission induction and consolidation regimen of patients either up to or over 60 years old) were drawn up and the medical profit was thereby estimated. Contrary to the Fee For Service system, with the DPC system the medical profit regarding patients with malignant lymphoma decreased because hospital stay was shortened. On the other hand for patients with AML the medical profit increased with the DPC system.
We therefore concluded that critical paths, which corresponded with the DPC system, are meaningful for the management of medical profits when treating hematological malignancies.
